Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis Launches Capital Increase Of 7.2 Million Euros

Oct 10 (Reuters) - VALBIOTIS SA  ALVAL.PA :
    * VALBIOTIS LAUNCHES A CAPITAL INCREASE WITH MAINTENANCE OF
THE
RIGHT PREFERENTIAL SUBSCRIPTION (SDA)
    * SUBSCRIPTION PRICE : EUR 2.35 PER SHARE
    * SUBSCRIPTION PERIOD: FROM OCTOBER 16, 2019 TO OCTOBER 28,
2019
INCLUSIVE
    * CAPITAL INCREASE OF EUR 7.2 MILLION WHICH MAY BE INCREASED
TO
EUR 8.3 MILLION IN EVENT OF EXERCISE OF THE EXTENSION CLAUSE
    * NEW STRATEGIC PRIORITY: CONCLUDE BEFORE END-2020
PARTNERSHIP
WITH MAJOR HEALTHCARE PLAYER THAT WILL PROVIDE FUNDING NEEDED TO
FINALIZE CLINICAL DEVELOPMENT OF VALEDIA
    * AROUND 2/3 TO BE DEDICATED TO RESEARCH AND DEVELOPMENT,
1/3 TO
"MARKET ACCESS"

Source text: https://bit.ly/2IEXIU9
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Valbiotis SA

See all news